Juraj Bies
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Oncology top 10%
- Cancer-related Molecular Pathways
- Peptidase Inhibition and Analysis
Papers in
-
- Ubiquitin and proteasome pathways 10
- Epigenetics and DNA Methylation 8
- Cancer-related gene regulation 5
- Hematology 20
- Acute Myeloid Leukemia Research 18
- Co-authors
- Linda Wolff (35 shared papers)Ján Markus (6 shared papers)Richard Koller (11 shared papers)Thomas A. Paul (2 shared papers)Marek Šramko (4 shared papers)Donald Small (1 shared paper)Martina E. Schmidt (2 shared papers)Peter Haviernik (3 shared papers)
- Journals
- Blood (5 papers)Oncogene (4 papers)Blood Cells Molecules and Diseases (4 papers)Journal of Biological Chemistry (4 papers)Journal of Virology (2 papers)
- Partner nations
- United StatesSlovakiaCanada
In The Last Decade
Juraj Bies
42 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 66
- Hematology 275
- Oncology 300
- Cancer Research 166
- Molecular Biology 805
- Immunology 162
Countries citing papers authored by Juraj Bies
This map shows the geographic impact of Juraj Bies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juraj Bies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juraj Bies more than expected).
Fields of papers citing papers by Juraj Bies
This network shows the impact of papers produced by Juraj Bies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juraj Bies. The network helps show where Juraj Bies may publish in the future.
Co-authors
The 25 scholars most cited alongside Juraj Bies, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 155 | |
| 2 | 2010 | 67 | |
| 3 | 2011 | 62 | |
| 4 | 2001 | 61 | |
| 5 | 2007 | 57 | |
| 6 | 1997 | 54 | |
| 7 | 2004 | 50 | |
| 8 | 2006 | 43 | |
| 9 | 2012 | 39 | |
| 10 | B-Myb prevents growth arrest associated with terminal differentiation of monocytic cells. | 1996 | 39 |
| 11 | Only late, nonmitotic stages of granulocyte differentiation in 32Dcl3 cells are blocked by ectopic expression of murine c-myb and its truncated forms. | 1995 | 37 |
| 12 | 2003 | 32 | |
| 13 | 2001 | 29 | |
| 14 | 2010 | 28 | |
| 15 | Acceleration of apoptosis in transforming growth factor beta 1-treated M1 cells ectopically expressing B-myb. | 1995 | 27 |
| 16 | 2000 | 25 | |
| 17 | 1999 | 24 | |
| 18 | 2012 | 21 | |
| 19 | 2012 | 21 | |
| 20 | 2013 | 20 |
About Juraj Bies
Juraj Bies is a scholar working on Molecular Biology, Hematology, Oncology, Genetics and Genetics, having authored 44 papers that have together received 1.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (18 papers), Ubiquitin and proteasome pathways (10 papers), Cancer-related Molecular Pathways (8 papers), Epigenetics and DNA Methylation (8 papers), Chronic Lymphocytic Leukemia Research (6 papers), Virus-based gene therapy research (6 papers), Cancer-related gene regulation (5 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Hematology (275 citations), Oncology (300 citations), Cancer Research (166 citations), Molecular Biology (805 citations) and Immunology (162 citations). Juraj Bies has collaborated with scholars based in United States, Slovakia and Canada. Frequent co-authors include Linda Wolff, Ján Markus, Richard Koller, Thomas A. Paul, Marek Šramko, Donald Small, Martina E. Schmidt, Peter Haviernik, Peter D. Aplan and Tomohiko Tamura. Their work appears in journals such as Blood, Oncogene, Blood Cells Molecules and Diseases, Journal of Biological Chemistry and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.